A British scientist dubbed ‘Dr. Pot’ and his business partner was last night celebrating a £94million windfall after selling their cannabis firm for £5.3billion. Dr. Geoffrey Guy founded Cambridge-based GW Pharmaceuticals in 1998 but is selling the company to Irish rival Jazz Pharmaceuticals. His holding will net him a payout of £65.9million, with the company’s long-serving chief executive Justin Gover expected to get £28.6million. GW Pharmaceuticals secured a Home Office license to grow cannabis in England and has pioneered marijuana treatments. Its first drug, mouth spray Sativex, was the first cannabis-based medicine to be approved by any country when it secured back in the UK for treatment of multiple sclerosis (MS) sufferers. Dr. Geoffrey Guy will take home £65.9million after selling his cannabis company, GW Pharmaceuticals, for £5.3billion to rivals in Ireland.
Matt Oliver, Daily Mail, 02/03/2021 19:59:00